spacer
home > ict > spring 2019 > enhancing the patient experience
PUBLICATIONS
International Clinical Trials

Enhancing the Patient Experience

The opportunities to strengthen patient engagement across all phases of clinical development have never been greater. We can now apply technology in creative ways to collect meaningful data from patients without increasing their burden as trial participants.

At the same time, empowered patients have high expectations of their health-related experiences in general, with clinical trial participation being no exception. As savvy consumers, patients expect technology to be both easy and enjoyable to use. Therefore, study sponsors and CROs should look to take advantage of the latest tools to ensure that a patientís involvement meets their expectations, fits into their daily lives to the greatest extent possible, and is, overall, a rewarding experience.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
James Munz is a product expert who has been solving business problems with cutting edge analytical and technical solutions for close to 20 years. As Vice President of eCOA Product Management, James is responsible for building and executing ERTís market-driven strategy for the eCOA product line. Prior to ERT, he was Vice President of Product at Opera Solutions where he was responsible for the development of a Big Data analytics platform used across supply chain, financial services, marketing, healthcare, and telecommunications industries. Additionally, he led one of the first products to leverage the Amazon Cloud.

Chris Watson PhD is a Product Strategist with 20 yearsí experience in the delivery of business and consumer-based solutions, the last 10 of which have been within the clinical technology industry. He has extensive knowledge of product and software development processes and is responsible for implementing the product strategy for ERTís digital patient business. Chris earned his PhD in Behavioural Neurosciences from the University of Nottingham, UK, and a BSc in pharmacology and toxicology, with honours, from the University of Bradford, UK.
spacer
James Munz
spacer
spacer
spacer
Chris Watson PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers
 
Industry Events

Clinical Innovation Partnerships

11-12 September 2019, Hotel Palace, Berlin

Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials. It is where the pharma, CRO and vendor clinical trials ecosystem meet to drive innovation in digitalisation, tech and partnering to improve patient experience and reduce trial cost and time.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement